4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-17-049448
EVP, R&D & Chief Scientific Of sold 7,604 shares at $14.75 ($112,159)
- EVP, R&D & Chief Scientific Of acquired 829 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Haqq Christopher EVP, R&D & Chief Scientific Of | 2017-08-15 | Option exercise | +829 | 362,909 | D | ||
| Haqq Christopher EVP, R&D & Chief Scientific Of | 2017-08-15 | Sale | −7,604 | $14.75 | $112,159 | 355,305 | D |
| Derivatives | |||||||
| Haqq Christopher EVP, R&D & Chief Scientific Of | 2017-08-15 | Option exercise · Restricted Stock Units | −829 | 1,382 | D | ||
| Open-market sales · 7,604 sh · avg $14.75 · $112,159 | |||||||
Loading xslF345X03/doc4.xml…